Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of personalized exercise program on physical function in elderly patients with rheumatoid arthritis at high risk for sarcopenia: study protocol for a randomized controlled trial.
Onishi A, Torii M, Hidaka Y, Uozumi R, Oshima Y, Tanaka H, Onizawa H, Fujii T, Murata K, Murakami K, Tanaka M, Matsuda S, Morinobu A, Arai H, Hashimoto M. Onishi A, et al. BMC Musculoskelet Disord. 2023 Apr 11;24(1):280. doi: 10.1186/s12891-023-06185-4. BMC Musculoskelet Disord. 2023. PMID: 37041556 Free PMC article.
Enteric Toll-like receptor 7 stimulation causes acute exacerbation in lupus-susceptible mice.
Takase Y, Shirakashi M, Nishida Y, Katsushima M, Onizawa H, Hiwa R, Tsuji H, Kitagori K, Akizuki S, Onishi A, Nakashima R, Murakami K, Yoshifuji H, Tanaka M, Tsuruyama T, Morinobu A, Hashimoto M. Takase Y, et al. Among authors: onishi a. Clin Rheumatol. 2023 Apr;42(4):1185-1194. doi: 10.1007/s10067-022-06467-7. Epub 2022 Dec 14. Clin Rheumatol. 2023. PMID: 36515794
Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and design.
Kojima M, Kawahito Y, Sugihara T, Kojima T, Harada R, Hirata S, Hashimoto M, Hidaka T, Ishikawa H, Ito H, Kishimoto M, Kaneko Y, Matsui K, Matsui T, Matsushita I, Morinobu A, Nishida K, Tanaka E, Abe A, Ishitoku M, Asai S, Kida T, Onishi A, Takanashi S, Harigai M. Kojima M, et al. Among authors: onishi a. BMC Rheumatol. 2022 Dec 26;6(1):90. doi: 10.1186/s41927-022-00322-7. BMC Rheumatol. 2022. PMID: 36567352 Free PMC article.
Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort.
Nakajima T, Doi H, Watanabe R, Murata K, Takase Y, Inaba R, Itaya T, Iwasaki T, Shirakashi M, Tsuji H, Kitagori K, Akizuki S, Nakashima R, Onishi A, Yoshifuji H, Tanaka M, Ito H, Hashimoto M, Ohmura K, Morinobu A. Nakajima T, et al. Among authors: onishi a. Mod Rheumatol. 2023 Dec 22;34(1):113-121. doi: 10.1093/mr/road014. Mod Rheumatol. 2023. PMID: 36680424
Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis.
Umemoto A, Kuwada T, Murata K, Shiokawa M, Ota S, Murotani Y, Itamoto A, Nishitani K, Yoshitomi H, Fujii T, Onishi A, Onizawa H, Murakami K, Tanaka M, Ito H, Seno H, Morinobu A, Matsuda S. Umemoto A, et al. Among authors: onishi a. Arthritis Res Ther. 2023 Feb 17;25(1):25. doi: 10.1186/s13075-023-03007-9. Arthritis Res Ther. 2023. PMID: 36804906 Free PMC article.
Pathogenicity of IgG-Fc desialylation and its association with Th17 cells in an animal model of systemic lupus erythematosus.
Nishida Y, Shirakashi M, Hashii N, Nakashima R, Nakayama Y, Katsushima M, Watanabe R, Onizawa H, Hiwa R, Tsuji H, Kitagori K, Akizuki S, Onishi A, Murakami K, Yoshifuji H, Tanaka M, Tsuruyama T, Morinobu A, Hashimoto M. Nishida Y, et al. Among authors: onishi a. Mod Rheumatol. 2024 Mar 28;34(3):523-529. doi: 10.1093/mr/road054. Mod Rheumatol. 2024. PMID: 37300805
IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study.
Nakayama Y, Watanabe R, Yamamoto W, Ebina K, Hirano T, Kotani T, Shiba H, Katayama M, Son Y, Amuro H, Onishi A, Jinno S, Hara R, Murakami K, Murata K, Ito H, Tanaka M, Matsuda S, Morinobu A, Hashimoto M. Nakayama Y, et al. Among authors: onishi a. Rheumatology (Oxford). 2024 Feb 1;63(2):349-357. doi: 10.1093/rheumatology/kead299. Rheumatology (Oxford). 2024. PMID: 37354495
Serum Concentrations of Infliximab and IL-6 for Predicting One-Year Discontinuation of Infliximab Treatment Owing to Secondary Non-response in Patients with Rheumatoid Arthritis.
Masui S, Yonezawa A, Nakamura M, Onishi A, Hashimoto M, Onizawa H, Fujii T, Murakami K, Murata K, Tanaka M, Yokoyama K, Iwamoto N, Shimada T, Itohara K, Hira D, Nakagawa S, Imai S, Nakagawa T, Hayakari M, Matsuda S, Morinobu A, Terada T, Matsubara K. Masui S, et al. Among authors: onishi a. Biol Pharm Bull. 2023;46(8):1112-1119. doi: 10.1248/bpb.b23-00192. Biol Pharm Bull. 2023. PMID: 37532562 Free article.
The role of semaphorin 3A on chondrogenic differentiation.
Tsuboi E, Asakawa Y, Hirose N, Yanoshita M, Sumi C, Takano M, Onishi A, Nishiyama S, Kubo N, Kita D, Tanimoto K. Tsuboi E, et al. Among authors: onishi a. In Vitro Cell Dev Biol Anim. 2024 May 10. doi: 10.1007/s11626-024-00909-z. Online ahead of print. In Vitro Cell Dev Biol Anim. 2024. PMID: 38727898
Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study.
Nakayama Y, Onishi A, Yamamoto W, Yoshikawa A, Shiba H, Yoshida N, Son Y, Shirasugi I, Maeda T, Katsushima M, Hashimoto M, Etani Y, Itami T, Nozaki Y, Onizawa H, Fujii T, Murakami K, Murata K, Tanaka M, Matsuda S, Morinobu A. Nakayama Y, et al. Among authors: onishi a. Clin Exp Med. 2024 May 10;24(1):97. doi: 10.1007/s10238-024-01360-w. Clin Exp Med. 2024. PMID: 38727756 Free PMC article.
408 results